Amphastar Pharmaceuticals AMPH Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's other non-current liabilities?
- Amphastar Pharmaceuticals (AMPH) reported other non-current liabilities of $29.37M in Q1 2026.
- How has Amphastar Pharmaceuticals's other non-current liabilities changed year-over-year?
- Amphastar Pharmaceuticals's other non-current liabilities increased by 20.2% year-over-year, from $24.42M to $29.37M.
- What is the long-term trend for Amphastar Pharmaceuticals's other non-current liabilities?
- Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's other non-current liabilities has grown at a 17.8% compound annual growth rate (CAGR), from $13.21M to $29.98M.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.